Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM On Twitter
  • JABFM On YouTube
  • JABFM On Facebook
Research ArticleOriginal Research

Are Amphetamines Associated with Adverse Cardiovascular Events Among Elderly Individuals?

James R. Latronica, Taylor J. Clegg, Wen-Jan Tuan and Curtis Bone
The Journal of the American Board of Family Medicine November 2021, 34 (6) 1074-1081; DOI: https://doi.org/10.3122/jabfm.2021.06.210228
James R. Latronica
the University of Pittsburgh School of Medicine, Department of Psychiatry; Department of Family Medicine, Pittsburgh, PA (JRL); Penn State Health Milton S. Hershey Medical Center, Hershey, PA, (TJC, WJT); Penn State Health Milton S. Hershey Medical Center, Department of Family and Community Medicine, Hershey, PA (CB).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taylor J. Clegg
the University of Pittsburgh School of Medicine, Department of Psychiatry; Department of Family Medicine, Pittsburgh, PA (JRL); Penn State Health Milton S. Hershey Medical Center, Hershey, PA, (TJC, WJT); Penn State Health Milton S. Hershey Medical Center, Department of Family and Community Medicine, Hershey, PA (CB).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen-Jan Tuan
the University of Pittsburgh School of Medicine, Department of Psychiatry; Department of Family Medicine, Pittsburgh, PA (JRL); Penn State Health Milton S. Hershey Medical Center, Hershey, PA, (TJC, WJT); Penn State Health Milton S. Hershey Medical Center, Department of Family and Community Medicine, Hershey, PA (CB).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Curtis Bone
the University of Pittsburgh School of Medicine, Department of Psychiatry; Department of Family Medicine, Pittsburgh, PA (JRL); Penn State Health Milton S. Hershey Medical Center, Hershey, PA, (TJC, WJT); Penn State Health Milton S. Hershey Medical Center, Department of Family and Community Medicine, Hershey, PA (CB).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Farzam K,
    2. Faizy RM,
    3. Saadabadi A
    . Stimulants. In: StatPearls. StatPearls Publishing; 2021. Updated August 6, 2021. Available at: http://www.ncbi.nlm.nih.gov/books/NBK539896/. Accessed March 9, 2021.
  2. 2.↵
    1. Calipari ES,
    2. Ferris MJ
    . Amphetamine mechanisms and actions at the dopamine terminal revisited. J Neurosci 2013;33:8923–5.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Safer DJ
    . Recent trends in stimulant usage. J Atten Disord 2016;20:471–7.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Piper BJ,
    2. Ogden CL,
    3. Simoyan OM,
    4. et al
    . Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016. PLOS ONE 2018;13:e0206100.
    OpenUrl
  5. 5.↵
    1. Berman SM,
    2. Kuczenski R,
    3. McCracken JT,
    4. London ED
    . Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol Psychiatry 2009;14:123–42.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Rajeh A,
    2. Amanullah S,
    3. Shivakumar K,
    4. Cole J
    . Interventions in ADHD: a comparative review of stimulant medications and behavioral therapies. Asian J Psychiatr 2017;25:131–5.
    OpenUrl
  7. 7.↵
    1. Arnsten AFT
    . Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology 2006;31:2376–83.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Hechtman L,
    2. Abikoff H,
    3. Klein RG,
    4. et al
    . Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry 2004;43:812–9.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Grimmsmann T,
    2. Himmel W
    . The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany. Eur J Clin Pharmacol 2021;77:107–15.
    OpenUrl
  10. 10.↵
    1. Dalsgaard S,
    2. Kvist AP,
    3. Leckman JF,
    4. Nielsen HS,
    5. Simonsen M
    . Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder: a nationwide prospective cohort study. J Child Adolesc Psychopharmacol 2014;24:302–10.
    OpenUrl
  11. 11.↵
    1. Hammerness PG,
    2. Karampahtsis C,
    3. Babalola R,
    4. Alexander ME
    . Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks? Expert Opin Drug Saf 2015;14:543–51.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Habel LA,
    2. Cooper WO,
    3. Sox CM,
    4. et al
    . ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 2011;306:2673–83.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Holick CN,
    2. Turnbull BR,
    3. Jones ME,
    4. Chaudhry S,
    5. Bangs ME,
    6. Seeger JD
    . Atomoxetine and cerebrovascular outcomes in adults. J Clin Psychopharmacol 2009;29:453–60.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Westover AN,
    2. Nakonezny PA,
    3. Haley RW
    . Acute myocardial infarction in young adults who abuse amphetamines. Drug Alcohol Depend 2008;96:49–56.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Westover AN,
    2. McBride S,
    3. Haley RW
    . Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry 2007;64:495–502.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Diaconu CC,
    2. Dediu GN,
    3. Iancu MA
    . Drug-induced arterial hypertension – a frequently ignored cause of secondary hypertension: a review. Acta Cardiologica 2018;73:511–7.
    OpenUrl
  17. 17.↵
    1. Stone NJ,
    2. Robinson JG,
    3. Lichtenstein AH
    , American College of Cardiology/American Heart Association Task Force on Practice Guidelines, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. J Am Coll Cardiol 2014;63:2889–934.
    OpenUrlFREE Full Text
  18. 18.↵
    1. Cheitlin MD
    . Cardiovascular physiology-changes with aging. Am J Geriatr Cardiol 2003;12:9–13.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Palombo C,
    2. Kozakova M
    . Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications. Vascul Pharmacol 2016;77:1–7.
    OpenUrlCrossRef
  20. 20.↵
    1. Stiefel G,
    2. Besag FMC
    . Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder. Drug Saf 2010;33:821–42.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Westover AN,
    2. Halm EA
    . Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review. BMC Cardiovasc Disord 2012;12:41.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Michielsen M,
    2. Kleef D,
    3. Bijlenga D,
    4. et al
    . Response and side effects using stimulant medication in older adults with ADHD: an observational archive study. J Atten Disord 2021; 1712–91.
  23. 23.↵
    1. Kalbag AS,
    2. Levin FR
    . Adult ADHD and substance abuse: diagnostic and treatment issues. Subst Use Misuse 2005;40:1955–81.
    OpenUrlPubMed
  24. 24.↵
    1. Dennis JA,
    2. Gittner LS,
    3. Payne JD,
    4. Nugent K
    . Characteristics of U.S. adults taking prescription antipsychotic medications, National Health and Nutrition Examination Survey 2013–2018. BMC Psychiatry 2020;20:483.
    OpenUrl
  25. 25.↵
    American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Amer Geri Soc 2015;63:2227–46.
    OpenUrl
  26. 26.↵
    1. Roose SP,
    2. Schatzberg AF
    . The efficacy of antidepressants in the treatment of late-life depression. J Clin Psychopharmacol 2005;25:S1–7.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Alexopoulos GS,
    2. Katz IR,
    3. Reynolds CF,
    4. Carpenter D,
    5. Docherty JP
    , Expert Consensus Panel for Pharmacotherapy of Depressive Disorders in Older Patients. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Postgrad Med 2001;1–86.
  28. 28.↵
    1. Satel SL,
    2. Nelson JC
    . Stimulants in the treatment of depression: a critical overview. J Clin Psychiatry 1989;50:241–9.
    OpenUrlPubMedWeb of Science
  29. 29.↵
    1. Lavretsky H,
    2. Reinlieb M,
    3. St Cyr N,
    4. Siddarth P,
    5. Ercoli LM,
    6. Senturk D
    . Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 2015;172:561–9.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Alexopoulos GS
    . Pharmacotherapy for Late-Life Depression. J Clin Psychiatry 2011;72:e04.
    OpenUrlPubMed
  31. 31.↵
    1. Dolder CR,
    2. Nicole Davis L,
    3. McKinsey J
    . Use of Psychostimulants in Patients with Dementia. Ann Pharmacother 2010;44:1624–32.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Young JJ,
    2. Lavakumar M,
    3. Tampi D,
    4. Balachandran S,
    5. Tampi RR
    . Frontotemporal dementia: latest evidence and clinical implications. Ther Adv Psychopharmacol 2018;8:33–48.
    OpenUrl
  33. 33.↵
    1. Sassi KLM,
    2. Rocha NP,
    3. Colpo GD,
    4. John V,
    5. Teixeira AL
    . Amphetamine use in the elderly: a systematic review of the literature. Curr Neuropharmacol 2020;18:126–35.
    OpenUrl
  34. 34.↵
    1. Torgersen T,
    2. Gjervan B,
    3. Lensing MB,
    4. Rasmussen K
    . Optimal management of ADHD in older adults. Neuropsychiatr Dis Treat 2016;12:
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family   Medicine: 34 (6)
The Journal of the American Board of Family Medicine
Vol. 34, Issue 6
November/December 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Are Amphetamines Associated with Adverse Cardiovascular Events Among Elderly Individuals?
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Are Amphetamines Associated with Adverse Cardiovascular Events Among Elderly Individuals?
James R. Latronica, Taylor J. Clegg, Wen-Jan Tuan, Curtis Bone
The Journal of the American Board of Family Medicine Nov 2021, 34 (6) 1074-1081; DOI: 10.3122/jabfm.2021.06.210228

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Are Amphetamines Associated with Adverse Cardiovascular Events Among Elderly Individuals?
James R. Latronica, Taylor J. Clegg, Wen-Jan Tuan, Curtis Bone
The Journal of the American Board of Family Medicine Nov 2021, 34 (6) 1074-1081; DOI: 10.3122/jabfm.2021.06.210228
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Appendix
    • Notes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Impact of a Pharmacist-Run Electronic Consult Service in a Network of Primary Care Patient-Centered Medical Homes
  • Integrating Harm Reduction into Medical Care: Lessons from Three Models
  • An Estimate of Severe Harms Due to Screening Colonoscopy: A Systematic Review
Show more Original Research

Similar Articles

Keywords

  • Amphetamine
  • Attention Deficit Disorder with Hyperactivity
  • Cardiology
  • Cardiovascular Diseases
  • Cohort Studies
  • Geriatric Psychiatry
  • Geriatrics
  • Heart Disease Risk Factors
  • Myocardial Infarction
  • Prescriptions
  • Retrospective Studies
  • Stroke

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2023 American Board of Family Medicine

Powered by HighWire